Review and analysis of clinical trials of selective RET inhibitors for the treatment of thyroid cancer
{{output}}
The global incidence of thyroid cancer has increased significantly, and patients with advanced, recurrent, or radioiodine-refractory disease face a severe shortage of effective treatment options. The RET proto-oncogene serves as a key driver in the development... ...
